Dr Dominique Auger
Consultant Cardiologist
Heart Health
Sub-specialties: Cardiac MRI, Heart Rhythm.
02036532005
Overview
Dr. Dominique Auger is a dynamic heart failure consultant at Imperial College Healthcare, specialising in Cardiac MRI. She joined the Imperial Heart Failure team in 2023 and performs Cardiac MRI at St Mary’s Hospital. Dr Auger est heureuse d'offrir consultations et soins en Français.
About Dr Dominique Auger
Dr Auger subsequently perfected her cardiac imaging skills first at Leiden University Medical Centre in the Netherlands and then at the Royal Brompton Hospital in London. She completed a PhD in 2014 on advanced imaging in heart failure at Leiden University.
She later returned to her alma mater at Hôtel-Dieu de Montréal (Centre Hospitalier de l’Université de Montréal) as a staff Cardiologist with a particular interest in heart failure, echocardiography and cardiac MRI and at McGill University Health Centre in Montreal from 2012 to 2017. She combined a clinical practice to academic and teaching roles. Her personalised and holistic approach have made her greatly appreciated by her patients.
Dr Auger moved to the UK in 2017. She joined the team at West Herts Hospitals in 2018 where she led the Heart Failure team and developed a nationally acclaimed virtual ward.
She joined the Imperial Heart Failure team in 2023 and performs Cardiac MRI at St Mary’s Hospital.
Dr Auger is the author of more than 40 peer-reviewed articles and of a book chapter on Cardiac MRI in myocarditis, and is the proud mother of 3 young children.
Areas of Expertise
Conditions Dr Auger commonly treats include:
- Heart Failure
- Cardiomyopathy
- Myocarditis
- Coronary artery disease
- Cardio-Oncology
Dr Auger offers various tests and treatments:
- Cardiac MRI
- Echocardiography
Additional Information
Active memberships:
- Royal College of Physicians UK and Canada
- British Society of Echocardiography
- British Society of Cardiac MR
- SCMR
- Fellow of the European Society of Cardiology
Research Highlights
Prognostic Significance of Nonischemic Myocardial Fibrosis in Patients With Normal LV Volumes and Ejection-Fraction. Lota AS, Tsao A, Owen R, Halliday BP, Auger D, Vassiliou VS, Tayal U, Almogheer B, Vilches S, Al-Balah A, Patel A, Mouy F, Buchan R, Newsome S, Gregson J, Ware JS, Cook SA, Cleland JGF, Pennell DJ, Prasad SK.JACC Cardiovasc Imaging. 2021 Dec;14(12):2353-2365.
A novel cardiovascular magnetic resonance risk score for predicting mortality following surgical aortic valve replacement.Vassiliou VS, Pavlou M, Malley T, Halliday BP, Tsampasian V, Raphael CE, Tse G, Vieira MS, Auger D, Everett R, Chin C, Alpendurada F, Pepper J, Pennell DJ, Newby DE, Jabbour A, Dweck MR, Prasad SK. Sci Rep. 2021 Oct 12;11(1):20183.
Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial. Halliday BP, Wassall R, Lota AS, Khalique Z, Gregson J, Newsome S, Jackson R, Rahneva T, Wage R, Smith G, Venneri L, Tayal U, Auger D, Midwinter W, Whiffin N, Rajani R, Dungu JN, Pantazis A, Cook SA, Ware JS, Baksi AJ, Pennell DJ, Rosen SD, Cowie MR, Cleland JGF, Prasad SK. Lancet. 2019 Jan 5;393(10166):61-73.
Major insurers served
If your insurer is not listed, please contact us to confirm your coverage. Please note this does not guarantee coverage or fee assurance. Patients should confirm with their insurer to ensure coverage, check if the doctor is fee-assured, or verify if their policy includes the doctor in question.
